Coming Soon! Access exclusive insights on PBM performance.
PSG’s supplement to the 2026 PBM Customer Satisfaction Report offers exclusive analysis of individual PBMs, helping you make smarter decisions.
What’s Inside:
- PBM-Specific Client Satisfaction Results
- The supplement provides detailed ratings for the following PBMs on a wide range of topics, including transparency, likelihood to recommend, and reasons for selecting the PBM
- PBMs featured are based on meeting a minimum number of respondents and include CVS Health, Express Scripts, OptumRx, Capital Rx, MedImpact, Navitus, and Prime Therapeutics
- General PBM Perceptions
- The supplement also includes general market perceptions, such as awareness, familiarity, overall impression, and inclusion in recent RFPs
- PBMs featured in this analysis were based on the survey design and include Abarca Health, AffirmedRx, Capital Rx, CarelonRx, CVS Health, Express Scripts, Liviniti, LucyRx, MedImpact, Navitus, OptumRx, Prime Therapeutics, ProAct, Rightway, and SmithRx
This supplement reveals each PBM’s unique strengths and challenges—essential for benchmarking against competitors or refining your strategy.
Ready to dive in?
